Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(84 sites)

United States

Kern Research, Inc, Bakersfield, California

Modena Allergy & Asthma, Inc., La Jolla, California

Antelope Valley Clinical Trials, Lancaster, California

Ark Clinical Research - Long Beach, Long Beach, California

Newport Native Md, Inc., Newport Beach, California